RxDoctor Payments Data

John Buenting, MD

Otolaryngology · Sylva, NCNPI 1285680066

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,938 of the $29,746 with a category attached, or 97.3%. Stryker accounts for 98.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $12,693 and has fallen 99.3% since, to $87 in 2025. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,746in general payments, 2019–2025

Across 60 payments — averaging $495.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$29K
  • Regeneron Healthcare Solutions, Inc.$119
  • Aerin Medical Inc.$89
  • Intersect ENT, Inc.$58
  • Medtronic$26
  • Organogenesis Inc.$25
  • plus $56 from 3 others

What the payments were for

  • Consulting fees$28,93897%
  • Food & beverage$8083%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,746 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$439,429
Medicare patients
627
Services billed
5,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl154$3,604
Ipratropium Bromide78$2,512
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,594
Fluticasone Propionate109$1,097
Mometasone Furoate11$797
Montelukast Sodium71$579
Famotidine66$540
Levocetirizine Dihydrochloride39$383
Doxycycline Hyclate31$362
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$329
Albuterol Sulfate HfaAlbuterol Sulfate14$316
Amoxicillin44$267
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim30$206
Mupirocin17$182
Azithromycin15$168

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Sylva

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →